Page last updated: 2024-10-25

ciglitazone and Uterine Cervical Neoplasms

ciglitazone has been researched along with Uterine Cervical Neoplasms in 3 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.

Research Excerpts

ExcerptRelevanceReference
"Ciglitizone may suppress human cervical cancer cells in PPAR-independent manner."1.33Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma. ( Bae, I; Bae, JH; Baek, WK; Cha, SD; Cho, CH; Jang, BC; Jung, TI; Kwon, KY; Song, DK; Suh, SI, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, HK1
Kim, DS1
Chae, JJ1
Kim, M1
Myong, JP1
Lee, KH1
Lee, MW1
Park, TC1
Wuertz, BR1
Darrah, L1
Wudel, J1
Ondrey, FG1
Jung, TI1
Baek, WK1
Suh, SI1
Jang, BC1
Song, DK1
Bae, JH2
Kwon, KY1
Cha, SD1
Bae, I1
Cho, CH1

Other Studies

3 other studies available for ciglitazone and Uterine Cervical Neoplasms

ArticleYear
Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells.
    Biochemical and biophysical research communications, 2017, Jan-22, Volume: 482, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Butadienes; Caspase 3; Cell Survival; Cervix Uteri; Chromans; Drug

2017
Thiazolidinediones abrogate cervical cancer growth.
    Experimental cell research, 2017, 04-15, Volume: 353, Issue:2

    Topics: Animals; Cell Differentiation; Cell Proliferation; Complement Factor D; Disease Models, Animal; Fema

2017
Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Gynecologic oncology, 2005, Volume: 97, Issue:2

    Topics: Carrier Proteins; Cell Cycle Proteins; Cell Growth Processes; Cell Line, Tumor; Cyclin-Dependent Kin

2005